Dia-Präsentation von Merck Gesellschaft mbH. Micardis(R) - Micardis Plus(R) - Klinische Wirksamkeit (39 Abbildungen) Übersicht | ||||||||||||||||||
Abbildung 34: Telmisartan - Valsartan - HCTZ The fixed-dose combination of telmisartan 80 mg/HCTZ 25 mg has been compared with valsartan 160 mg/HCTZ 25 mg in an 8-week placebo-controlled study.1 The study recruited 1109 patients with mild-to-moderate hypertension. Telmisartan/HCTZ significantly reduced trough cuff SBP and DBP compared with valsartan/HCTZ. 1. Data on file. Boehringer Ingelheim GmbH. |
Abbildung 34: Telmisartan - Valsartan - HCTZ
The fixed-dose combination of telmisartan 80 mg/HCTZ 25 mg has been compared with valsartan 160 mg/HCTZ 25 mg in an 8-week placebo-controlled study.1 The study recruited 1109 patients with mild-to-moderate hypertension. Telmisartan/HCTZ significantly reduced trough cuff SBP and DBP compared with valsartan/HCTZ. 1. Data on file. Boehringer Ingelheim GmbH. |
